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INTRODUCTION:  Angiosarcomas  of  the  breast  are  a rare  subtype  of sarcomas  that  frequently  are  diagnosed
after radiation  therapy  for primary  breast  cancer.  Primary  angiosarcomas  are  rare  entities  accounting
0.05%  of  all  malignant  breast  neoplasm.
PRESENTATION  OF  CASE:  We  report  a case  of  primary  angiosarcoma  of the  breast  in  a  25 years  woman,
with no  previous  radiotherapy,  treated  with  a  total  mastectomy  followed  by  radio-chemotherapy.
DISCUSSION:  Total  mastectomy  appears  to be the  only  treatment  known  that  has  proven  to  beneﬁt these
patients.  Adjuvant  treatment  has  not  proven  value  up until  today.  The  5-year  disease  free  survival  forrimary angiosarcoma
reast cancer
oung woman
astectomy
iffusion-weighted magnetic resonance
maging (MR-DWI)
grade  1 tumors  can be as  high  as 76%,  and  up  to  15%  for grade  3.
CONCLUSION:  Due  to  the  rarity  of these  tumors  there  is  no standard  therapies  approach.
©  2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).adiotherapy
. Introduction
Primary breast angiosarcomas are rare malignant vascular neo-
lasias that originate from the breast parenchyma and occasionally
ffect the skin. Globally, angiosarcoma represents less than 0.05%
f all breast cancers [1].
Breast angiosarcomas usually affect women in the thirties or
orties. Clinically they appear as a painless, irregular breast mass
2] that occasionally grow fast [3].
Secondary malignancy usually occurs in elderly women with a
istory of radiotherapy for breast cancer with an incidence rate
rom 0.04% to 0.15% [4].
The best treatment for breast angiosarcomas is a simple mas-
ectomy. Axillary lymphadenectomy is not needed, due to the fact
hat angiosarcomas tend to metastasize by vascular spread [1].
. Case report
A 25 year-old Caucasian woman presents a bulky breast mass
nvolving entire right breast. The patient referred having a 2 cm
ized lump two years earlier in a right breast. Several breasts ultra-
ound were informed as benign ﬁndings. In the last 6 months she
elt a quick growth of the mass, but did not consult any doctor until
t reached 14 cm in its size. She had no history of breast trauma and
o breast cancer in her family.
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 1,28223 Pozuelo de Alarcon, Madrid, Spain.
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ttp://dx.doi.org/10.1016/j.ijscr.2016.05.015
210-2612/© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/).On physical exam we  found a bulky and irregular breast mass of
approximately 14 cm causing important breast asymmetry (Fig. 1),
and skin devitalization secondary to the distension reaching the
inframammary groove. No suspicious lymphadenopathies were
palpated at the diagnosis.
The diffusion-weighted magnetic resonance imaging (MR-DWI)
revealed a 14 × 13 × 10.5 cm mass with solid and hypervascularized
components with signiﬁcant enhancement, type 3-curve and high
apparent diffusion coefﬁcient (ADC) (1,85–3,17 × 10–3 mm2/s).
Areas with intratumoral bleeding were also identiﬁed.
The right breast was  completely occupied by the tumor, leaving
a small amount of residual breast tissue surrounded by a pseudo-
capsule caused by tumor effect (Fig. 2). A diagnostic core needle
biopsy was  performed. The ﬁnal histology was read as a grade 1
angiosarcoma of the breast. Metastatic work-up was negative by
PET-Scan.
A nipple sparing simple mastectomy was  needed to remove the
tumor. Nipple-areola skin biopsies were sent during the procedure
for intraoperative pathological study to rule out skin inﬁltra-
tion. The ﬁnal pathology report conﬁrmed the diagnosis of breast
angiosarcoma grade 1 with free surgical margins and no skin
inﬁltration. Breast reconstruction was  performed during the pro-
cedure, placing a retropectoral expander, which was  replaced by a
deﬁnitive implant after completed radiotherapy. The patient opted
for oocyte cryopreservation prior chemotherapy. The case was
discussed in the multidisciplinary Tumor Committee deciding sub-
sequent adjuvant treatment with 4 cycles of chemotherapy with
ifosfamide-Adriamycin, followed by 12 weeks of weekly taxol, and
breast radiotherapy.
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Fig. 1. Right breast’s mass that causes great asymmetry with ulceration and trophic
skin changes.
Fig. 2. Mass with intratumoral bleeding areas and solid areas with signiﬁcant
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Lnhancement hypervascular with type 3 curve and apparent diffusion coefﬁcient
ADC) tall (1.85–3.17 × 10–3 mm2/s), with a compression of pseudocapsule breast
issue residual.
The patient is asymptomatic and free of disease 13 months after
he diagnosis.
. Discussion
Primary breast angiosarcoma is a rare tumor usually affecting
omen in their early forties. The majority of these tumors are diag-
osed with a history of breast radiotherapy [5]. However they also
ppear without previous risky factors like the one described in this
ase.
The 5-year overall survival for grade 1 breast angiosarcomas is
pproximately 75% and 15% for grade 3 tumors [6].
Approximately 2% of the patients with breast angiosarcoma
ay  present with diffuse increase breast volume and skin changes
bluish red coloration). To the date nearly all case reports, present
o correlation between the size of the tumor and the survival rate
7].
Angiosarcoma is often initially misdiagnosed and preoperative
iagnosis by biopsy can be difﬁcult. The ﬁne needle aspiration
s controversial given the extensive vascularity of the tumor [6].
arge-core biopsies might facilitate the correct diagnosis as theyPEN  ACCESS
rgery Case Reports 24 (2016) 101–103
provide a larger sample, but such a macro biopsy is often difﬁcult
to perform due to the vascular nature of these tumors.
MRI  is the best imaging test for characterizing breast angiosarco-
mas, due to the fact that it allows a better assessment of the regional
distribution and visualizes the vascular nature of the lesion, help-
ing in the diagnosis. In our case we  used diffusion MRI, allowing
a better lesion characterization and more accurate assessment
of local involvement, including skin and pectoral muscle inva-
sion.
Primary angiosarcomas present on MR  imaging as a hetero-
geneous masses with low signal intensity on T1W images and
high signal on T2W images. High-grade tumors may  demonstrate
rapid enhancement with washout kinetics, but lower grade tumors
usually demonstrate plateau or persistent enhancement kinetics.
High-grade tumors can also demonstrate focal areas of high signal
on T1-weighting images, reﬂecting hemorrhage or vascular lakes
[8].
The best treatment of breast angiosarcoma is surgery, perform-
ing a free margin simple mastectomy as soon as possible.
We performed a sparing nipple mastectomy for the young age
of the patient. The big question is that technique was  associated
a higher risk of local recurrence, even if the skin biopsy was  nega-
tive. Literature shown that nipple sparing mastectomy can be safely
performed for breast cancer treatment in carefully selected cases.
In a study of Memorial Sloan-Kettering Cancer Center where ana-
lyze the nipple sparing mastectomy for breast cancer found that
the 39 nipple-areola complexes (100%) were intact and there were
no local or systemic recurrences in cases treated for cancer [9].
Although there is no experience described in literature related to
breast angiosarcoma.
Axillary dissection is not indicated, as nodal involvement is
rare. Skin ulceration or muscle involvement requires adjuvant
chemotherapy and radiotherapy. No randomized studies on the
role of radiation therapy after surgery for breast angiosarcoma have
been published to the date and no systematic therapeutic approach
has been described in the literature due to the rarity of this tumor
[3].
Local recurrences can appear after surgery in approximately one
third of the patients diagnosed with primary angiosarcoma, sug-
gesting that surgery alone often leads to inadequate local tumor
control. We perform adjuvant chemotherapy in our case, based on
several studies that have compared chemotherapy regimens based
on epirubicin and ifosfamide versus no treatment showing a signiﬁ-
cant improvement in disease-free survival in those patients treated
with chemotherapy [10].
4. Conclusion
The importance of this case is to emphasize that primary breast
angiosarcoma can develop in breasts with no previous history
of radiation. Breast masses with heterogeneous hyperechogenic-
ity on ultrasound exploration, along with distorted architecture
should suggest the radiologist the diagnosis of breast angiosar-
coma, diagnostic core needle biopsy should be performed in all
cases regardless the age of the patient.
Breast angiosarcoma presents no standard therapeutic
approach till the moment, due to the rarity of this tumor and
its idiosyncrasies. Surgery with posterior adjuvant chemotherapy
and/or radiotherapy remain as the main treatments to the moment
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